These are the 6 startups selected for the first edition of the Health & BioTech Accelerator:
Cardiolyse. Finnish startup that has developed a “device agnostic” data analytics cloud platform for cardiac telemonitoring, with personalized reports and risk stratification for each patient. In particular, Cardiolyse takes raw data from wearable and portable devices and transforms them into structured and usable information, so that healthcare professionals and doctors can quickly take the most appropriate action towards the client.
EGC247. Norwegian startup that has patented the “ECG247 Smart Heart Sensor”, an innovative wireless device for remote cardiac monitoring, specifically for the detection of atrial fibrillation and other cardiac arrhythmias. The device allows continuous monitoring of patients during their daily activities, including sports ones, allowing the detection of cardiac events, even mild ones, and the immediate reporting of them to the patient and the attending physician.
Kither Biotech. Italian biopharmaceutical startup that is developing new therapies for rare lung disorders. The company holds the patent for a compound for the treatment of Cystic Fibrosis for which pre-clinical data have shown that, when used in conjunction with currently used drugs, it improves the therapeutic efficacy and potentially the quality of life of patients. To date, Kither has raised EUR 5.6 million and is about to launch a Series B round to continue further with the development of the molecule and the clinical phases.
MicroMesh. Research Project of Istituto Italiano di Tecnologia that is developing a polymeric implant, “uMesh”, for the treatment of glioblastoma multiforme (GBM). The therapeutic implant is a biocompatible and biodegradable network that facilitates the deep permeation of drugs into the tumor site, significantly increasing the efficacy of the therapy, as demonstrated by pre-clinical studies.
Vaxxit. Italian biopharmaceutical startup that develops vaccines against HIV, Herpes Simplex Virus (HSV) and M. Tuberculosis (TB), diseases indicated by the WHO among the global health priorities. The startup is currently conducting a clinical study for the validation of an HIV vaccine.
Wearable Robotics. Italian startup founded in 2014 as spin-off of the Scuola Superiore Sant’Anna of Pisa that develops and produces different types of robotic exoskeletons for clinical and industrial applications. In particular, it has developed the “ALExRS” robotic solution, a bilateral exoskeleton for the upper limbs rehabilitation of neurological patients, which is already in use in various centers in Italy and in Europe. Moreover, the possible application of ALExRS for orthopedic rehabilitation is currently being evaluated.